Author Information
Leif Erik Sander is a prominent researcher affiliated with the Department of Infectious Diseases and Pulmonary Medicine at Charité-Universitätsmedizin Berlin. This institution is a corporate member of both the Freie Universität Berlin and Humboldt-Universität zu Berlin, as well as the Berlin Institute of Health, located in Berlin, Germany. Dr. Sander's work primarily focuses on infectious diseases, with a particular emphasis on the study of SARS-CoV-2 and its implications on public health.Research Contributions
Dr. Sander has made significant contributions to the understanding of SARS-CoV-2, particularly in the context of immunization and immune response. His research in 2022 has explored various aspects of COVID-19, including the efficacy of mRNA booster immunizations against the Omicron variant, the durability of immune responses in older adults, and the effects of SARS-CoV-2 on the brain. Moreover, he has investigated the impact of pre-existing conditions such as multiple sclerosis on vaccine efficacy and has assessed the use of antimicrobials and co-infections in hospitalized COVID-19 patients. Dr. Sander's work is crucial in guiding public health responses and vaccination strategies against COVID-19.Aliases
Dr. Leif Erik Sander is known by several aliases, including Leif E. Sander, L E Sander, L. E. Sander, Le Sander, Leif Sander, Leif-erik Sander, Leif E Sander, L.-e. Sander, and L. Sander. These variations may appear in different publications and databases.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
11852 |
| h-index |
49 |
| Total Paper Count |
202 |
